Immunocore
IMCR
#4848
Rank
โ‚น165.17 B
Marketcap
โ‚น3,269
Share price
-2.12%
Change (1 day)
31.42%
Change (1 year)

Revenue for Immunocore (IMCR)

Revenue in 2025 (TTM): โ‚น32.84 Billion

According to Immunocore's latest financial reports the company's current revenue (TTM ) is โ‚น34.44 Billion. In 2022 the company made a revenue of โ‚น18.07 Billion an increase over the revenue in the year 2021 that were of โ‚น3.68 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immunocore from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น32.84 B
2022 โ‚น18.07 B389.97%
2021 โ‚น3.68 B-2.54%
2020 โ‚น3.78 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA